HYFT
ImmunoPrecise Antibodies Ltd.
1.30$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 93.6% | 88.2% | 83.6% | 19.5% | 34.8% | 28.2% | 73.0% | 40.1% | 21.6% | 19.1% | 42.2% | 75.9% | |
| 8.4% | 24.7% | 65.6% | 7.3% | 19.3% | 9.6% | 62.4% | 32.1% | 10.6% | 5.8% | 24.0% | 53.1% | |
| 87.0% | 40.2% | 65.6% | 7.3% | 19.3% | 9.6% | 62.4% | 32.1% | 10.6% | 5.8% | 24.0% | 53.1% | |
| 4.3% | 32.7% | 11.9% | 9.0% | 6.9% | 13.4% | 5.4% | 3.6% | 5.0% | 6.8% | 10.8% | 16.8% | |
| – | 0.2% | 1.5% | 1.7% | 7.5% | 3.0% | 1.8% | 1.7% | 2.6% | 3.6% | 4.7% | 2.3% | |
| – | – | – | 19.9% | 29.1% | 29.0% | 11.6% | 21.1% | 24.6% | 12.8% | 18.5% | 0.0% | |
| 2.9% | – | – | 16.4% | 29.7% | 30.4% | 9.0% | 34.6% | 39.7% | 39.3% | 2.4% | – | |
| 552.2% | 34.2% | 21.3% | 48.3% | 36.3% | 44.7% | 15.0% | 19.6% | 25.7% | 43.5% | 46.8% | 45.0% | |
| 552.2% | 27.9% | 21.3% | 17.4% | 25.4% | 29.1% | 9.1% | 9.9% | 7.6% | 13.5% | 20.3% | 27.1% | |
| 160.4% | – | – | 0.8% | 10.0% | 10.5% | 2.7% | 2.5% | 2.5% | 2.6% | 4.2% | 2.1% | |
| 391.8% | 7.3% | 16.9% | 8.3% | 5.6% | 5.0% | 2.0% | 5.1% | 3.2% | 7.3% | 11.9% | 19.5% | |
| -452.2% | 65.8% | 78.7% | 51.7% | 63.7% | 55.3% | 85.0% | 80.5% | 74.3% | 56.5% | 53.2% | 55.0% | |
| -41,046.7% | 65.8% | -116.2% | -39.6% | -61.7% | -82.5% | -44.5% | -49.8% | -93.9% | -167.1% | -289.8% | -667.8% | |
| 1,192.9% | 144.8% | 100.8% | 37.1% | 44.2% | 50.0% | 24.6% | 21.1% | 32.0% | 42.7% | 75.1% | 217.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.